A 34-gene Expression Biomarker Predicts Meningioma Outcomes and Radiotherapy Responses
Overview
Authors
Affiliations
A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
Nguyen M, Morshed R, Youngblood M, Perlow H, Lucas C, Patel A Neuro Oncol. 2024; 27(2):445-454.
PMID: 39340366 PMC: 11812033. DOI: 10.1093/neuonc/noae198.
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy.
Choudhury A, Cady M, Lucas C, Najem H, Phillips J, Palikuqi B Cancer Discov. 2024; 14(10):1823-1837.
PMID: 38742767 PMC: 11452293. DOI: 10.1158/2159-8290.CD-23-1459.
Wang J, Landry A, Raleigh D, Sahm F, Walsh K, Goldbrunner R Neuro Oncol. 2024; 26(10):1742-1780.
PMID: 38695575 PMC: 11449035. DOI: 10.1093/neuonc/noae082.